Anne Lebrun

Title: The Innovative Contributions of Anne Lebrun

Introduction

Anne Lebrun is a prominent inventor based in Paris, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase inhibitors. Her work has the potential to impact the treatment of various diseases.

Latest Patents

Anne Lebrun holds a patent for "Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors." This invention relates to compounds of formula (I), which include various defined components such as R1, R2, L, X, R3, A, R4, R', R'', R5, Y, and L. The patent emphasizes the use of these compounds as protein kinase inhibitors and outlines methods for treating diseases through their administration. She has 1 patent to her name.

Career Highlights

Anne is currently associated with Aventis Pharma S.A., where she continues to innovate and contribute to pharmaceutical research. Her expertise in the field has positioned her as a valuable asset in the development of new therapeutic agents.

Collaborations

Throughout her career, Anne has collaborated with notable colleagues, including Hartmut Strobel and Sven Ruf. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Anne Lebrun's work exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions, particularly in the area of kinase inhibitors, highlight the importance of research in developing new treatments for diseases.